Biosimilars: presumption of guilt
Some chronic systemic diseases, including diabetes mellitus, require the life-long use of biotechnological medical products, of which quality,effectiveness and safety depends the duration and quality of life for patients.Patent protection expiry of many original biological agents has assumed the key...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN RU |
| Publié: |
Endocrinology Research Centre
2011
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/b1538ef0741c4c26a0787930c7008414 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|